<DOC>
	<DOCNO>NCT00974376</DOCNO>
	<brief_summary>This clinical study evaluate efficacy medication gabapentin treat person cannabis dependence .</brief_summary>
	<brief_title>Gabapentin Treatment Cannabis Dependence</brief_title>
	<detailed_description>This 12-week , double blind , placebo control study evaluate efficacy gabapentin treat outpatient cannabis dependence . After initial phone screen , comprehensive screen visit schedule determine eligibility . Baseline assessment use measurement instrument conduct cannabis use , neuropsychological functioning , withdrawal , crave , pain , mood sleep . Upon enrollment , counseling , medication dispensation research assessment occur 1 time per week 3 month include assessment withdrawal , crave , pain , mood sleep . A final , follow-up visit occur end 3 month .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Males female 1865 year age Meets DSM IV criterion current cannabis dependence Seeking researchbased outpatient treatment cannabis dependence involve daily medication Smoked MJ daily least 25 day per month 90 day prior randomization At least 2year history regular MJ use Abstinent cannabis 2 day time randomization Active suicidal ideation Currently meet DSM IV criterion abuse dependence substance , urine drug screen positive substance , cannabis nicotine Significant medical disorder increase potential risk interfere study participation , Sexually active female participant childbearing potential pregnant , nursing refuse use reliable method birth control Meets DSM IV criterion major AXIS I disorder cannabis nicotine dependence , Inability understand and/or comply provision protocol consent form Treatment investigational drug previous month Sensitivity study drug evidence adverse drug experience gabapentin ingredient Ongoing treatment medication may affect study outcome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Cannabis Treatment</keyword>
	<keyword>Cannabis Use</keyword>
	<keyword>Cannabis Dependence</keyword>
	<keyword>Executive Functioning</keyword>
	<keyword>Cognitive Deficits</keyword>
</DOC>